Can Dental Device Test Reports Be Reused for Overseas Registration?

Key Summary

Whether dental device test reports can be reused for overseas registration depends on the regulatory system of the target country, the product's risk classification, the applicable testing standards, and the qualifications of the issuing laboratory. Manufacturers should first determine whether the product falls under the target country's medical device regulatory scope, confirm the risk classification and registration pathway, and then assess whether existing NMPA registration test reports, CE test reports, FDA 510(k) test data, or ISO 13485 system audit reports can be submitted directly or after localization.

Performance validation, biocompatibility testing, and risk management reports in the core technical documentation generally have high reusability. However, attention must be paid to differences in standard versions, the recognized scope of laboratory accreditations, and local official language requirements. Labeling, instructions for use, clinical evaluation or clinical evidence, local agent authorization, and post-market surveillance systems must be re-prepared in accordance with the target country's regulations. Manufacturers should organize the evidence chain early, verify that the issuing laboratory holds ISO/IEC 17025 or GLP accreditation, and assess whether supplementary testing or retesting is necessary.

Common risks include submitting inapplicable reports, overlooking standard differences, and failing to confirm report acceptability in advance, leading to extended correction cycles. A well-planned report reuse strategy can significantly reduce duplicate testing costs and accelerate time-to-market in multiple countries.

Applicable Scenarios and Core Questions

When preparing for overseas registration, dental device manufacturers frequently ask whether test reports already completed in China or other markets can be submitted directly to the target country's regulatory authority. This decision affects timelines, costs, and the overall success of the registration.

Report reuse is not simply a matter of having a report; it requires answering three core questions: Does the target country accept the standard basis of the report? Is the issuing laboratory recognized by the target country? Do the test items cover the technical requirements for registration in the target country? If any of these is uncertain, reuse may lead to requests for correction or rejection.

Dental devices encompass a wide range of products, from X-ray machines and dental chairs to implants, root canal files, impression materials, and orthodontic brackets. Their risk classifications vary significantly, from low to high risk. Different target countries impose different requirements. For example, some Southeast Asian countries accept CE reports as technical evidence but require translation into the local language; certain Middle Eastern countries require confirmation by a local authorized representative; Latin American countries may require the issuing laboratory to be a member of the International Laboratory Accreditation Cooperation (ILAC).

Manufacturers must understand that report reuse is not a one-time decision but an ongoing assessment that spans registration strategy, technical documentation preparation, handling of deficiency letters, and post-market surveillance.

Registration Judgment Logic

To determine whether test reports can be reused, manufacturers must first confirm whether the product falls under the target country's medical device regulatory scope. Most countries classify dental devices as medical devices, but specific classifications may differ. For instance, dental wax might be classified as Class I in one country and Class II in another, directly affecting the required test items.

The second step is to determine the risk classification and registration pathway. GHWP member countries generally adopt risk-based classification rules. The higher the risk, the stricter the review of technical documentation and the higher the requirements for the form and content of test reports. For high-risk implantable dental devices, target countries often require full testing reports against specific standards, and may also require site audits or batch testing.

The third step is to assess the reusability of existing reports. Manufacturers should establish a complete report inventory and compare each report against the target country's official list of technical documentation and testing standard catalogs. For example, if the domestic registration test is based on YY/T 0268 or GB/T 16886 series, while the target country adopts ISO 10993 series, version differences and test method alignment must be confirmed.

The fourth step is to confirm localization requirements. Even if the report content is fully applicable, translation into the target country's official language is often required. Some countries also require notarization or certification by a local notary or authorized representative. Additionally, the product name, model, and manufacturer name on the report must match the information in the registration application exactly.

Finally, manufacturers should plan for post-market maintenance. If the product design, raw material supplier, or sterilization process changes after the report is issued, the report may no longer be valid and a re-assessment will be necessary.

Documentation and Evidence

When reusing test reports, manufacturers need to prepare a complete evidence chain. Primary documents include the original report, the Chinese or English version, and laboratory qualification certificates such as CNAS accreditation, ISO/IEC 17025 accreditation, or GLP certificates.

For CE reports, it is recommended to provide the EU Notified Body certificate and the Notified Body number. For FDA reports, provide the U.S. laboratory registration information and relevant test summaries, and if applicable, a 510(k) substantial equivalence summary.

The performance validation section in the technical documentation should be traceable to the test report. Manufacturers should prepare product technical requirements or specifications that identify the test sample model, batch, and production date, ensuring consistency with the sample information in the test report.

Risk management reports are a key focus in the review of report reuse. Submit risk management documentation compliant with ISO 14971, identifying all risks related to the test items and explaining how risk control measures are validated by the test results.

Biocompatibility test reports require special attention to applicable standards. If the existing report is based on an older version of ISO 10993, version differences and additional requirements must be assessed. For reports reused across markets, compliance with the latest ISO 10993-1 requirements should be verified.

Compliance evidence for labeling and instructions for use cannot be derived from test reports. Manufacturers must prepare label documents that meet the target country's language, symbol, and warning requirements, and have them reviewed and confirmed.

A local agent or authorized representative's power of attorney is a mandatory document for overseas registration. Even if test reports are fully reused, incomplete agent documentation will prevent the registration application from being accepted.

Common Mistakes

• Assuming that test reports do not expire and ignoring standard updates, resulting in submission of outdated report versions.
• Submitting domestic registration test reports directly without checking whether the testing laboratory is on the target country's recognized list, causing failure in formal review.
• Overlooking inconsistencies between the product model in the report and the model in the registration application, leading to deficiency requests.
• Failing to assess whether biocompatibility endpoints cover the target country's requirements, resulting in retesting for high-risk products.
• Submitting translations without required notarization or certification, rendering them invalid in the target country.
• Confusing test reports with declarations of conformity, using self-declarations in place of mandatory test reports.
• Reusing old test reports after product design or material changes, creating a risk of false content in registration dossiers.
• Failing to confirm in advance whether the target country requires on-site inspection of the testing laboratory, leading to additional laboratory audits.

Manufacturer Preparation Checklist

• List all existing test reports, including report number, issue date, standard basis, test items, sample information, and laboratory qualifications.
• Create a comparison table of target country registration requirements, verifying test item coverage item by item.
• Obtain copies of laboratory qualification certificates and international cooperation recognition documents, and prepare translations and notarizations.
• Confirm the product risk classification and registration pathway, and when necessary, conduct pre-submission inquiries with consulting firms or target country regulatory authorities.
• Establish a report version control mechanism to ensure that the submitted reports are the latest valid versions.
• Prepare product technical documentation, risk management reports, and performance validation materials as supporting evidence for the test reports.
• If supplementary testing is required, contact laboratories with target country-recognized accreditation as early as possible.
• Confirm that the local agent is capable of handling report translation, notarization, and supplementary submissions.

AIMEILI Insights

The most common misjudgment manufacturers make regarding report reuse is assuming that reports are universally accepted. In reality, target country regulators value not merely the report itself but the testing capability, standard compliance, and completeness of the evidence chain behind it. Directly using NMPA reports for Southeast Asian registrations, or submitting CE reports without explanation for Latin American registrations, often leads to deficiency letters or rejection.

At the early stage of a project, conduct a comprehensive report inventory rather than searching for reports one by one after registration has started. It is recommended to establish a report library by product line and target market, recording laboratory qualifications, testing standard versions, sample information, and certificate validity. This makes it easier to decide which reports can be used directly, which require supplementary testing, and which must be redone by a different laboratory.

Test items based on international standards, such as ISO 10993 biocompatibility, ISO 7405 dental material testing, and ISO 19429 implant fatigue testing, are generally reusable. However, labeling, package inserts, clinical evaluation or clinical evidence, and local language versions of technical summaries must be localized. Even test reports themselves may need additional testing required by the target country, such as heavy metal release testing.

Local agent, certificate control, changes, and renewal are long-term risks that are often overlooked. When reusing test reports, verify that the local agent has the ability to handle report translation and communication with authorities. The registration certificate must be controlled by the manufacturer itself, not solely by the agent. Subsequent changes such as production site changes, standard updates, or product upgrades may require new test reports, so manufacturers should confirm in advance the traceability and update support of the laboratory.

For multi-country registration, it is advisable to adopt a core report portfolio strategy. Use standard test reports from an in-house or long-term partner laboratory as the foundation, and then create localized cover pages, translations, and supplementary tests for each country, rather than conducting full testing again for every country. This approach significantly reduces duplicate rework and deficiency risks, while improving registration efficiency.

FAQ Follow-up Questions

Can a valid CE test report be used directly for Saudi FDA registration?

The Saudi FDA recognizes certain international standards, but requires reports from laboratories it has recognized. Not all CE reports are directly acceptable. Manufacturers must first confirm whether the testing laboratory is on the Saudi FDA's recognized list, check differences between ISO standard versions and Saudi technical regulations, and consider whether additional Saudi-specific tests are required. Report translation and local agent authorization are also necessary.

Is a domestic registration test report valuable for Southeast Asian registration?

Domestic registration test reports can serve as technical references, but most Southeast Asian countries do not directly accept CNAS reports as registration evidence. Typically, the report data must be converted into ISO-compliant formats and submitted by a local agent or authorized representative. Some countries, such as Thailand and Malaysia, accept ISO 13485 system certification and product test reports compliant with ISO standards. Manufacturers can assess whether existing reports meet these requirements.

Can original test reports still be used if there is a minor design change?

This depends on whether the change affects product safety and performance. If the change involves materials, structure, sterilization methods, or intended use, the original reports are likely not directly reusable, and relevant tests must be repeated. If the change is only to labeling or non-functional appearance, original reports can be retained, but a change description and risk assessment must be submitted. The basic principle is that any change must undergo an impact assessment and be documented in the technical file.

Continue Reading

Previous: How to organize technical documentation for overseas registration of dental devices? Next: How to use ISO 13485 certificates for overseas registration of dental devices?

Recommended Reading

• Can test reports be reused for overseas registration of software medical devices?
• What are the requirements for risk management documents for overseas registration of implantable products?
• How to organize technical documentation for overseas registration of dental devices?
• How to use ISO 13485 certificates for overseas registration of dental devices?
• How to conduct post-market surveillance for overseas registration of dental devices?
• What are the requirements for risk management documents for overseas registration of dental devices?

Content Review and Applicability

Content author: AIMEILI Regulatory Editorial Team. Professional review: AIMEILI Medical Device International Registration Project Team. Sources: Priority is given to official regulatory bodies, international organizations, standards organizations, and publicly available regulatory materials; industry media and project experience are used only as supplementary references.

Applicability: This article is intended for preliminary understanding, documentation preparation, and project planning. It does not replace formal requirements, test conclusions, or legal advice from regulatory authorities in the target country.